par Andre, Fabrice;Dieci, Maria V;Dubsky, Peter;Sotiriou, Christos ;Curigliano, Giuseppe;Denkert, Carsten;Loi, Sherene
Référence Clinical cancer research, 19, 1, page (28-33)
Publication Publié, 2013-01
Référence Clinical cancer research, 19, 1, page (28-33)
Publication Publié, 2013-01
Article révisé par les pairs
Titre: |
|
Auteur: | Andre, Fabrice; Dieci, Maria V; Dubsky, Peter; Sotiriou, Christos; Curigliano, Giuseppe; Denkert, Carsten; Loi, Sherene |
Informations sur la publication: | Clinical cancer research, 19, 1, page (28-33) |
Statut de publication: | Publié, 2013-01 |
Sujet CREF: | Cancérologie |
Sciences biomédicales | |
MeSH keywords: | Antibodies, Monoclonal -- pharmacology -- therapeutic use |
Antineoplastic Agents -- pharmacology -- therapeutic use | |
Breast Neoplasms -- drug therapy -- immunology -- metabolism | |
Drug Resistance, Neoplasm | |
Female | |
Humans | |
Lymphocytes, Tumor-Infiltrating -- immunology -- metabolism | |
Receptor, erbB-2 -- metabolism | |
Signal Transduction -- drug effects | |
T-Lymphocytes, Regulatory -- immunology -- metabolism | |
Translational Medical Research | |
Treatment Outcome | |
Note générale: | Journal Article |
Review | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1078-0432 |
info:doi/10.1158/1078-0432.CCR-11-2701 | |
info:pii/1078-0432.CCR-11-2701 | |
info:scp/84871949633 | |
info:pmid/23258741 |